
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly ...
Feb 18, 2025 · Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help …
Gilead Presents New HIV Treatment and Cure Research Data at …
2 days ago · About Gilead HIV. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal …
First Clinical Data for Gilead’s Investigational Once-Yearly ...
3 days ago · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once …
Gilead Presents New HIV Treatment and Cure Research Data at …
2 days ago · FOSTER CITY, Calif., March 12, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its …
Gilead Presents New HIV Treatment and Cure Research Data
2 days ago · About Gilead HIV. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal …
Gilead Sciences, Inc. - First Clinical Data for Gilead’s ...
3 days ago · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once …
Gilead Sciences: Innovative HIV Prevention and Treatment
We introduced the first once-daily oral medication for pre-exposure prophylaxis (PrEP) to help prevent HIV transmission between sexual partners when taken as prescribed. This …
Gilead Presents New HIV Treatment And Cure Research Data
1 day ago · On Wednesday, Gilead Sciences, Inc. GILD presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI …
Gilead Sciences, Inc. - U.S. FDA Accepts Gilead’s New Drug …
Feb 18, 2025 · Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help …
Gilead data suggests yearly shot of PrEP drug blocks HIV …
2 days ago · Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six …